JPRN-UMIN000010715招募中未知
Comparison of insulin glargine and insulin degludec in type 2 diabetes by continuous glucose monitoring system - Comparison of insulin glargine and insulin degludec in type 2 diabetes by continuous glucose monitoring system
Mie Chuo Medical Center0 个研究点目标入组 30 人开始时间: 2013年5月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)patient with poor glycemic control (2)Type 1 diabetes (3)secondary diabetes (4)unstable diabetic complication active proliferative retinopaty untreated cardiovascular disease (5) Patient hospitalized or changed treartment within three months (6) noncompliance Irregular life (Night shift pursuer) (7)not willing to use CGM, SMBG (8)Judged as ineligible by clinical investigators
研究者
相似试验
尚未招募
不适用
Comparison study between insulin glargine and decludec on the glucose fluctuation in Type 2 diabetic patients treated with basal insulin and oral hypoglycemic agents.JPRN-UMIN000012138Kyorin University of Medicine30
已完成
3 期
Comparision of glargine insulin and Regular insulin on quality of perioperative glucose controlType 2 diabetes mellitus.Type 2 diabetes mellitusIRCT20141127020112N8Iran University of Medical Sciences80
已完成
不适用
Comparison of Insulin degludec vs. Insulin glargine using continuous glucose monitoring (CGM): Crossover studyJPRN-UMIN000010847Ichinomiyanishi Hospital16
进行中（未招募）
不适用
Comparative investigation of Insuline glargine versus Metformin as first line drug in treat-ment of early Type 2 Diabetes (GLORY) - GLORYDiabetes mellitus Type IIMedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-006860-12-DEGWT-TUD GmbH100
进行中（未招募）
不适用
Impact of Insulin Glargine compared to Insulin Detemir in combination with Metformin (BOT) on prandial beta cell function and overall metabolic control in type 2 diabetic patients with insufficient metabolic control during OAD Treatment - Insulin glargine and prandial beta cell functionDiabetes mellitus Type 2MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2007-006109-26-DEInstitut für Klinische Forschung und Entwicklung (ikfe) GmbH